ACELYRIN announced the appointment of Patricia Turney as Chief Technical Operations Officer. Reporting to Founder and CEO Shao-Lee Lin, MD, PhD, Ms. Turney will be responsible for overseeing technical operations, CMC regulatory, corporate quality and facilities, and will join the company’s Senior Leadership Team. Turney most recently served as Senior Vice President, Operations at Arcutis Biotherapeutics, Inc., where she built the Technical Operations organization to successfully execute on their product development milestones including several product filings and the first Commercial Product launch in the U.S. and Canada. Prior to that, Ms. Turney held roles of increasing responsibility with Amgen.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SLRN:
- ACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023
- Acelyrin management to meet virtually with Piper Sandler
- Acelyrin appoints Mpofu as Senior Vice President of Development
- Zura Bio’s approach could be ‘promising’ in HS, says Guggenheim
- Acelyrin downgraded to Equal Weight from Overweight at Morgan Stanley